Zepp Health Corp 6-K, filed Mar 16, 2026

Zepp Health Corp (ZEPP)

6-K 2026-03-16 For: 2026-03-16

Added on April 06, 2026

About this 6-K

Zepp Health Corp filed this 6-K on March 16, 2026.

	As of December 31,		As of December 31,
	2024		2025
	US$		US$
Assets
Current assets:
Cash and cash equivalents		91,069		57,046
Restricted cash		19,666		55,887
Accounts receivable, net		62,965		66,908
Amounts due from related parties		2,663		6,665
Inventories, net		56,789		72,756
Short-term investments		997		-
Prepaid expenses and other current assets		17,415		34,263
Total current assets		251,564		293,525

Property, plant and equipment, net		6,898		5,662
Intangible asset, net		7,091		13,611
Goodwill		9,581		9,581
Long-term investments		225,910		220,047
Deferred tax assets		17,465		15,743
Amount due from related parties, non-current		2,019		991
Other non-current assets		4,607		3,718
Operating lease right-of-use assets		3,458		1,958
Total assets		528,593		564,836

	As of December 31,		As of December 31,
	2024		2025
	US$		US$
Liabilities
Current liabilities:
Accounts payable		51,077		80,768
Advance from customers		197		76
Amount due to related parties		2,477		654
Accrued expenses and other current liabilities		37,576		37,527
Income tax payables		508		366
Notes payable		61,679		111,725
Short-term bank borrowings		41,853		55,728
Total current liabilities		195,367		286,844
Deferred tax liabilities		3,117		2,673
Long-term borrowings		75,241		59,475
Other non-current liabilities		133		209
Non-current operating lease liabilities		2,007		1,102
Total liabilities		275,865		350,303

	For the Three Months Ended December 31,
	2024			2025
	US$			US$
Revenues		59,542			85,165
Cost of revenues		(37,613	)		(50,750	)
Gross profit		21,929			34,415
Operating expenses:
Selling and marketing		(13,251	)		(15,929	)
General and administrative		(6,555	)		(11,375	)
Research and development		(11,061	)		(10,982	)
Total operating expenses		(30,867	)		(38,286	)
Operating loss		(8,938	)		(3,871	)

Other income and expenses:
Interest income		771			322
Interest expense		(1,447	)		(1,616	)
Gain/(Loss) from fair value change of long-term investments		33			(358	)
Impairment loss from investments		(10,129	)		(2,194	)
Other expense, net		(767	)		(222	)
Loss before income tax and loss from equity method investments		(20,477	)		(7,939	)
Income tax expenses		(13,574	)		(2,068	)
Loss before loss from equity method investments		(34,051	)		(10,007	)
Net loss from equity method investments		(2,850	)		(964	)
Net loss		(36,901	)		(10,971	)
Less: Net loss attributable to noncontrolling interest		(25	)		-
Net loss attributable to Zepp Health Corporation		(36,876	)		(10,971	)

Basic and diluted net loss per share attributable to Zepp Health Corporation		(0.14	)		(0.04	)

Basic and diluted net loss per ADS (16 ordinary shares equal to 1 ADS)		(2.29	)		(0.69	)

Weighted average number of shares used in computing basic and diluted net loss per share		257,216,039			254,033,558

	Years Ended December 31,
	2024			2025
	US$			US$
Revenues		182,603			258,897
Cost of revenues		(112,369	)		(159,707	)
Gross profit		70,234			99,190
Operating expenses:
Selling and marketing		(46,471	)		(53,829	)
General and administrative		(24,854	)		(29,273	)
Research and development		(46,159	)		(45,318	)
Total operating expenses		(117,484	)		(128,420	)
Operating loss		(47,250	)		(29,230	)

Other income and expenses:
Interest income		3,672			1,526
Interest expense		(5,552	)		(5,697	)
Gain from fair value change of long-term investments		2,011			76
Impairment loss from investments		(10,129	)		(2,194	)
Other(expense) /income, net		(656	)		56
Loss before income tax and loss from equity method investments		(57,904	)		(35,463	)
Income tax expenses		(13,693	)		(2,537	)
Loss before loss from equity method investments		(71,597	)		(38,000	)
Net loss from equity method investments		(4,211	)		(2,068	)
Net loss		(75,808	)		(40,068	)
Less: Net loss attributable to noncontrolling interest		(75	)		-
Net loss attributable to Zepp Health Corporation		(75,733	)		(40,068	)

Basic and diluted net loss per share attributable to Zepp Health Corporation		(0.29	)		(0.16	)

Basic and diluted net loss per ADS (16 ordinary shares equal to 1 ADS)		(4.68	)		(2.52	)

Weighted average number of shares used in computing basic and diluted net loss per share		258,876,120			254,431,492

	As of December 31,			As of December 31,
	2024			2025
	US$			US$
Equity
Ordinary shares		26			26
Additional paid-in capital		278,116			281,990
Treasury stock		(14,993	)		(16,153	)
Accumulated retained earnings/(loss)		28,618			(11,450	)
Accumulated other comprehensive loss		(40,178	)		(39,880	)
Total Zepp Health Corporation shareholders’ equity		251,589			214,533
Noncontrolling interest		1,139			-
Total equity		252,728			214,533
Total liabilities and equity		528,593			564,836